KRAS and lung carcinoma: Review of the cBioPortal datasets gave us further insight to conduct an overall survival comparison between low and high mRNA expression levels of cytosolic NADPH generating enzymes in lung cancer patients with KRAS wild type (WT) and KRAS mutation.